Jacquelyn Smith, RN, BSN, MA, CMCN
Regional Vice President, Program Operations SW
Amerigroup Community Care
Robert Terkeltaub, MD
Rheumatology Section Chief
San Diego VA Medical Center
Professor of Medicine
University of California
San Diego, CA
Michelle Martin, RN, BSN, MHSA, CPHQ, CMCN, CCM, CPC-A
Director of Medicare Operations--Nevada and California
Las Vegas, NV
Nurses: 1 Contact Hour
Nurse Case Managers: 1 Clock Hour Medium
THIS ACTIVITY WAS ORIGINALLY PRESENTED AS A LIVE AUDIOCONFERENCE SERIES BEGINNING MARCH 31, 2010. IF YOU RECEIVED CREDIT FOR PARTICIPATING IN THE AUDIOCONFERENCE, YOU ARE NOT ELIGIBLE TO RECEIVE CREDIT FOR THIS ONLINE ACTIVITY.
Each year, approximately 3 million U.S. adults are affected by gout. Repeated attacks of gout are common; an initial gouty attack recurs in up to 60% of individuals within 1 year, 78% within 2 years, and as many as 93% within 10 years. The rising incidence and prevalence of gout and hyperuricemia has been attributed to the increasing at-risk population, including patients with hypertension, diabetes, hyperlipidemia, chronic kidney disease, and metabolic syndrome. In addition, suboptimal management of gout is recognized as a likely contributor to the recent rise in symptomatic, chronic gout.
Acute gouty arthritis, with its associated painful joint inflammation, can become a chronic, persistent condition and, if not managed properly, can lead to permanent joint destruction. Nurses in the managed care setting can play a vital role in improving this increasingly common disorder, thereby slowing the progression and reducing the associated health and economic burdens. This educational activity will address how to identify patients at risk for gout and compare the risks and benefits of traditional and emerging therapies to decrease serum uric acid concentrations. The presenters will help participants understand barriers to appropriate management of gout, identify critical topics for patient education, and develop adherence-promoting strategies.
. Target Audience
This educational activity is designed for managed care nurses and nurse case managers.
Upon completion of this educational activity, the participant should be able to:
Identify patients who are at risk for gout, including those with common comorbidities.
Compare the risks and benefits of traditional and emerging therapeutic approaches.
Identify the barriers to appropriate treatment of gout.
Identify community needs and available resources for gout management.
List important topics to cover when educating patients about their role in preventing and self-managing gout.
As an educational provider AAMCN must insure balance, independence, objectivity, and scientific rigor in all its individually sponsored or jointly sponsored activities. All faculty participating in an activity are expected to disclose to the sponsor any real or potential conflict of interest and to the audience any significant financial relationship or affiliation (1) with the manufacturer of any commercial product and/or provider of commercial services discussed in any educational presentation and (2) with any commercial supporters of the activity. The intent of this disclosure is not to prevent a speaker with a significant financial or other relationship from making a presentation, but rather to provide the listeners with information on which they can make their own judgments.
Ms. Smith has no real or perceived conflicts of interest that relate to this presentation.
Dr. Terkeltaub discloses that he has the following real or perceived conflicts of interest that relate to this presentation: He has received honoraria from Takeda Pharmaceuticals North America, Savient Pharmaceuticals, Pfizer Inc, Regeneron, URL Pharma, Ardea Biosciences, and Novartis Pharmaceuticals.
Ms. Martin has no real or perceived conflicts of interest that relate to this presentation.
The planning committee and staff of AAMCN and Medical Communications Media, Inc., have no financial relationships that present a real or perceived conflict of interest.
This educational activity may contain discussion of published and/or investigational treatments used in the management of gout. Some uses may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Nursing Continuing Education: The American Association of Managed Care Nurses has been approved as a provider of continuing education by the Virginia Nurses Association (VNA). VNA is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Commission on Accreditation. 1.0 contact hour will be awarded to nurses who complete this activity.
This activity has been approved by the Commission for Case Management for 1 clock hour towards recertification. Approval number CM474-A206.
There is no fee to participate in this activity.
Commercial Support Statements
Supported by an educational grant from Takeda Pharmaceuticals North America.
Please turn off all pop-up blockers.
Click on the "Start program" icon. If you are not already logged in to the site, this will bring you to the login/registration page where you will be able to register as a new cmecorner.com member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen.
Complete the short survey and click on "done."
The next screen will permit you to check for or download the Flash player required to run this program and to begin the program presentation. This activity will require approximately 60 minutes to complete.
After the program has finished, click on the "Post-test" button. Complete the short survey and click on "done."
Instructions for completing and submitting the post-test and program evaluation are provided on the post-test screen. A credit certificate will be awarded for a score of 70% or better and may be printed immediately after passing the post-test.